Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert E Kim

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Communications|November 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Medicine|June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial resultsPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Neuro-Oncology|December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistanceAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Cancer Immunology Research|June 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Communications|November 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Communications|October 13, 2021
Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastasesSanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson, et al.
Nature Medicine|June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial resultsPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
Nature Communications|October 13, 2021
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosisPriscilla K Brastianos, Matthew R Strickland, Eudocia Quant Lee, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Structural and functional vascular dysfunction within brain metastases is linked to pembrolizumab inefficacyAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Neuro-Oncology|December 9, 2023
Abnormal vascular structure and function within brain metastases is linked to pembrolizumab resistanceAlbert E Kim, Kevin W Lou, Anita Giobbie-Hurder, et al.
Cancer Immunology Research|June 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking, et al.
Pageof 3